225 related articles for article (PubMed ID: 7894497)
1. CYP3A gene expression in human gut epithelium.
Kolars JC; Lown KS; Schmiedlin-Ren P; Ghosh M; Fang C; Wrighton SA; Merion RM; Watkins PB
Pharmacogenetics; 1994 Oct; 4(5):247-59. PubMed ID: 7894497
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues.
McKinnon RA; Burgess WM; Hall PM; Roberts-Thomson SJ; Gonzalez FJ; McManus ME
Gut; 1995 Feb; 36(2):259-67. PubMed ID: 7883227
[TBL] [Abstract][Full Text] [Related]
3. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver.
Schuetz JD; Beach DL; Guzelian PS
Pharmacogenetics; 1994 Feb; 4(1):11-20. PubMed ID: 8004129
[TBL] [Abstract][Full Text] [Related]
4. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta.
Schuetz JD; Kauma S; Guzelian PS
J Clin Invest; 1993 Aug; 92(2):1018-24. PubMed ID: 8349787
[TBL] [Abstract][Full Text] [Related]
5. Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism.
Lin YS; Dowling AL; Quigley SD; Farin FM; Zhang J; Lamba J; Schuetz EG; Thummel KE
Mol Pharmacol; 2002 Jul; 62(1):162-72. PubMed ID: 12065767
[TBL] [Abstract][Full Text] [Related]
6. Genetic contribution to variable human CYP3A-mediated metabolism.
Lamba JK; Lin YS; Schuetz EG; Thummel KE
Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645
[TBL] [Abstract][Full Text] [Related]
7. Expression and localization of CYP3A4 and CYP3A5 in human lung.
Anttila S; Hukkanen J; Hakkola J; Stjernvall T; Beaune P; Edwards RJ; Boobis AR; Pelkonen O; Raunio H
Am J Respir Cell Mol Biol; 1997 Mar; 16(3):242-9. PubMed ID: 9070608
[TBL] [Abstract][Full Text] [Related]
8. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3.
Schmiedlin-Ren P; Thummel KE; Fisher JM; Paine MF; Lown KS; Watkins PB
Mol Pharmacol; 1997 May; 51(5):741-54. PubMed ID: 9145912
[TBL] [Abstract][Full Text] [Related]
9. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.
Lown KS; Kolars JC; Thummel KE; Barnett JL; Kunze KL; Wrighton SA; Watkins PB
Drug Metab Dispos; 1994; 22(6):947-55. PubMed ID: 7895614
[TBL] [Abstract][Full Text] [Related]
10. Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum.
Canaparo R; Finnström N; Serpe L; Nordmark A; Muntoni E; Eandi M; Rane A; Zara GP
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1138-44. PubMed ID: 17880367
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers.
Hakkola J; Raunio H; Purkunen R; Saarikoski S; Vähäkangas K; Pelkonen O; Edwards RJ; Boobis AR; Pasanen M
Biol Neonate; 2001; 80(3):193-201. PubMed ID: 11585982
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma.
Bergheim I; Bode C; Parlesak A
BMC Gastroenterol; 2005 Nov; 5():34. PubMed ID: 16281975
[TBL] [Abstract][Full Text] [Related]
13. Bimodal distribution of renal cytochrome P450 3A activity in humans.
Haehner BD; Gorski JC; Vandenbranden M; Wrighton SA; Janardan SK; Watkins PB; Hall SD
Mol Pharmacol; 1996 Jul; 50(1):52-9. PubMed ID: 8700118
[TBL] [Abstract][Full Text] [Related]
14. Expression of cytochrome P450 3A4 in foveolar epithelium with intestinal metaplasia of the human stomach.
Yokose T; Doy M; Kakiki M; Horie T; Matsuzaki Y; Mukai K
Jpn J Cancer Res; 1998 Oct; 89(10):1028-32. PubMed ID: 9849581
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression.
Gibbs MA; Thummel KE; Shen DD; Kunze KL
Drug Metab Dispos; 1999 Feb; 27(2):180-7. PubMed ID: 9929500
[TBL] [Abstract][Full Text] [Related]
16. Selective expression of CYP3A5 and not CYP3A4 in human blood.
Janardan SK; Lown KS; Schmiedlin-Ren P; Thummel KE; Watkins PB
Pharmacogenetics; 1996 Oct; 6(5):379-85. PubMed ID: 8946469
[TBL] [Abstract][Full Text] [Related]
17. Isolation of CYP3A5P cDNA from human liver: a reflection of a novel cytochrome P-450 pseudogene.
Schuetz JD; Guzelian PS
Biochim Biophys Acta; 1995 Mar; 1261(1):161-5. PubMed ID: 7893755
[TBL] [Abstract][Full Text] [Related]
18. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism.
Mei Q; Tang C; Assang C; Lin Y; Slaughter D; Rodrigues AD; Baillie TA; Rushmore TH; Shou M
J Pharmacol Exp Ther; 1999 Nov; 291(2):749-59. PubMed ID: 10525096
[TBL] [Abstract][Full Text] [Related]
19. Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.
Lacroix D; Sonnier M; Moncion A; Cheron G; Cresteil T
Eur J Biochem; 1997 Jul; 247(2):625-34. PubMed ID: 9266706
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens.
von Richter O; Burk O; Fromm MF; Thon KP; Eichelbaum M; Kivistö KT
Clin Pharmacol Ther; 2004 Mar; 75(3):172-83. PubMed ID: 15001968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
